Introduction
============

The hepatitis E virus (HEV) is a non-enveloped, single-stranded, positive-sense RNA virus responsible for acute icteric viral hepatitis. The World Health Organization estimates 20 million HEV infections worldwide yearly with over three million acute cases and 57,000 deaths^[1](#fn01){ref-type="fn"}^. In Europe, the number of confirmed cases of HEV has increased 10 times in the last decade ([@B10]), making HEV issue a trending topic ([@B22]; [@B48]).

Human-to-human transmission of HEV has been reported due to infected organ transplantations and blood transfusions, while maternal-fetal transmission can also occur, being the HEV-related scenario with the highest mortality rates (up to 25% in pregnant women). However, fecal-oral transmission has been increasingly identified as the most important infection route ([@B49]). In particular, contaminated drinking water is the main factor responsible for epidemic outbreaks in developing countries, while clustered or single cases in high-income countries are often related to zoonotic transmissions by consumption of raw or undercooked meat originating from infected reservoir animals (domestic pigs and wild boars) or direct contact with the infected animals ([@B22]; [@B31]; [@B39]; [@B42]).

In view of the changing epidemiology, the availability of reliable and widely applicable techniques for detection and quantification of HEV in environmental and food samples has become even more important. Molecular methods, particularly real-time reverse transcriptase polymerase chain reaction (RT-qPCR), have demonstrated high sensitivity, specificity, and ability to deliver reliable quantitative data in food and environmental samples ([@B26], [@B25]; [@B8]; [@B27]), although such results do not indicate at the infectivity of detected viruses. In addition, alternative strategies to directly study infectivity such as cell culture systems and animal models do not seem to be reliable or practical yet ([@B36]; [@B50]), although promising results have been reported ([@B12]; [@B19]; [@B17]). To enable the differentiation between infectious and inactivated viral particles, different approaches based on capsid integrity have been reported:

1.  selective recovery of potentially infectious norovirus (NoV) by binding to porcine gastric mucin (PGM) before extraction ([@B45]; [@B47]; [@B7]; [@B9]);

2.  treatments with nucleases and/or proteolytic enzymes before extraction in order to remove any signal from damaged capsid ([@B23]; [@B29]; [@B40]);

3.  treatments with intercalating dyes before extraction, either with a photoactivation step (i.e., propidium and ethidium monoazide) ([@B11]; [@B35], [@B32]) or without (i.e., platinum and palladium compounds) ([@B13]);

4.  long-template qPCR likely detecting genome alterations ([@B3]; [@B43]).

Each listed strategy has some drawbacks or cannot easily be applied in the case of HEV. For instance, the inactivation of cultivable viruses, like the hepatitis A virus (HAV), has shown discrepancies when assessed by photoactivatable intercalating dyes coupled with RT-qPCR compared with cell culture ([@B33]). Similarly, long-template PCR assays decrease the amplification efficiency limiting its use especially for food-related application with expected low contamination levels ([@B51]). Moreover, selective recovery of potentially infectious HEV particles by a binding approach cannot be developed because the specific receptors are not clearly defined ([@B50]).

In this study, three previously described HEV assays ([@B24]; [@B34]) were coupled with two viability markers propidium monoazide (PMAxx) and platinum chloride (PtCl~4~) and initially evaluated on purified viral RNA. The optimized viability RT-qPCR method was then applied to native, heat-, and high-pressure processing (HPP)-treated HEV to assess its performance in discriminating between potentially infectious and inactivated viral particles. HAV was used in parallel as a cultivable counterpart to HEV.

Materials and Methods {#s1}
=====================

Viral Strains
-------------

Fecal sample containing HEV genotype 3f (kindly provided by Dr. Alcaraz, Hospital Clínico Universitario, Valencia, Spain) was suspended (10%, wt/vol) in phosphate-buffered saline (PBS) containing 2 M NaNO~3~ (Panreac, Spain), 1% beef extract (Conda, Spain), and 0.1% Triton X-100 (Fisher Scientific, United States) (pH 7.2), vortexed, and centrifuged at 1000 × *g* for 5 min. The supernatant was stored at −80°C in aliquots.

The cytopathogenic HM-175/18f strain of HAV (ATCC VR-1402) was propagated and assayed in FRhk-4 cells (kindly provided by Prof. Bosch, University of Barcelona, Spain). HAV infectivity was calculated by determining the 50% tissue culture infectious dose (TCID~50~) after visual inspection of cells for presence of cytopathic effect with eight wells per dilution and 20 μl of inoculum per well using the Spearman--Karber method ([@B44]; [@B21]).

Virus Extraction and Quantification
-----------------------------------

Viral RNA extraction was carried out on 150 μl of viral suspension using a NucleoSpin^®^ RNA virus kit (Macherey-Nagel GmbH & Co.) according to the manufacturer's instructions. Primers, probes and RT-qPCR conditions used in this study are listed in **Table [1](#T1){ref-type="table"}** for HEV and in the ISO 15216:2017 for HAV. Modified-probe included in assay A ([@B41]) contains a ZEN internal quencher. Modification of assay C (adapted from [@B24]) consists of an RT reaction held at 45°C for 60 min. RT-qPCRs were carried out in 96-well plates using the LightCycler 480 instrument (Roche Diagnostics) and a half-scale modification of the RNA UltraSense One-Step quantitative RT-PCR system (Invitrogen SA), by using half volumes of all reagents.

###### 

HEV RT-qPCR assays used in this study.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------
  Assay   Amplified region   Primers and probe   Sequence 5′--3′                          RT-qPCR conditions     Location^∗^           References
  ------- ------------------ ------------------- ---------------------------------------- ---------------------- --------------------- ----------------------------
  A       ORF3               HEV.Fa\             GTGCCGGCGGTGGTTTC\                       RT 50° C for 30 min\   5296--5377 (81 nt)    [@B41] with modified probe
                             HEV.Fb\             GTGCCGGCGGTGGTTTCTG\                     95°C for 15 min\                             
                             HEV.R\              GCGAAGGGGTTGGTTGGATG\                    PCR (45×)\                                   
                             HEV.P               FAM-TGACMGGGT/ZEN/TGATTCTCAGCC/3IABkFQ   95°C for 10"\                                
                                                                                          55°C for 25"\                                
                                                                                          72°C for 25"                                 

  B       ORF2/3             JVHEVF\             GGTGGTTTCTGGGGTGAC\                      RT 50°C for 30 min\    5304--5373 (69 nt)    [@B20]
                             JVHEVR\             AGGGGTTGGTTGGATGAA\                      95°C for 15 min\                             
                             JVHEVP              FAM-TGATTCTCAGCCCTTCGC-BHQ               PCR (45×)\                                   
                                                                                          95°C for 10"\                                
                                                                                          55°C for 20"\                                
                                                                                          72°C for 15"                                 

  C       ORF2               HEV.F\              GACAGAATTRATTTCGTCGGCTGG\                RT 45° C for 60 min\   6341--6530 (189 nt)   [@B24] with modifications
                             HEV.R\              TGYTGGTTRTCATAATCCTG\                    95°C for 10 min\                             
                             HEV.P               FAM-GTYGTCTCRGCCAATGGCGAGCNT-BHQ         PCR (50×)\                                   
                                                                                          95°C for 15"\                                
                                                                                          60°C for 60"                                 
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------

∗

Location in reference to WHO International Standard for HEV RNA, HRC-HE104 strain, accession no. AB630970 (

Baylis et al., 2013

).

Quality control of the RT-qPCR process included negative (nuclease-free water) and positive (RNA) controls added to each PCR plate. Each viral RNA was analyzed in duplicate. HEV and HAV quantification was calculated by plotting the quantification cycles (Cqs) to an external standard curve built with the International Standard WHO HEV RNA (250,000 IU/ml) and HAV reference material (code RM000HAV, Public Health England), respectively.

Evaluation of Intercalating Dye Treatment on Purified HEV RNA
-------------------------------------------------------------

PMAxx^TM^ (Biotium) was dissolved in water to obtain 4 mM solution and stored protected from light at −20°C. Platinum (IV) chloride (PtCl~4~) (Acros Organics, Morris Plains, NJ, United States), was dissolved in dimethyl sulfoxide (DMSO, Sigma-Aldrich) at 50 mM concentration and stored at −20°C for later use.

Both PMAxx^TM^ and PtCl~4~ were initially evaluated on HEV RNA purified using the NucleoSpin^®^ RNA virus kit. In particular, PMAxx (1.9 μl) at 50, 100 and 250 μM was initially incubated with HEV RNA (150 μl) in DNA LoBind 1.5 ml tubes (Eppendorf) at room temperature (RT) for 10 min in a shaker at 150 rpm. Then, samples were immediately exposed to 15 min photoactivation using a photo-activation system (Led-Active Blue, GenIUL). Similarly, purified HEV RNA (150 μl) was incubated with PtCl~4~ (1.5 μl) at 50, 100, 500, and 1000 μM in DNA LoBind 1.5 ml tubes at 5°C for 30 min in a shaker at 150 rpm ([@B13]). Each experiment was performed in triplicate. HEV RNA (150 μL) without viability marker was used as a positive control. After viability pretreatments, RNA was purified again using the NucleoSpin^®^ RNA virus and quantified by RT-qPCR as reported above.

Performance of PtCl~4~ Pretreatments to Discriminate Potentially Infectious and Thermally Inactivated HEV
---------------------------------------------------------------------------------------------------------

Initially, HEV-fecal suspension was diluted in PBS at approx. 4 and 5 log~10~ IU/ml and heat-treated at 99°C for 5 min. Then, suspensions were incubated with PtCl~4~ at 500 μM in DNA LoBind 1.5 ml tubes at 5°C for 30 min in a shaker at 150 rpm. Three types of controls were included in the experiments: potentially infectious viruses treated with PtCl~4~, and potentially infectious and thermally inactivated viruses without PtCl~4~ pretreatment. Each experiment was performed in triplicate. After PtCl~4~ treatment, RNA was extracted using the NucleoSpin^®^ RNA virus kit according to the manufacturer's instructions and HEV RNA was detected using the assay A ([@B41]).

Thermal Treatment of HEV and HAV
--------------------------------

In addition, to further study HEV inactivation kinetics and the performance of PtCl~4~ treatment to discriminate between potentially infectious and thermally inactivated virus, HEV-fecal suspension at approx. 6 log~10~ IU/ml were treated at 60, 72, and 95°C for 15 min in a thermal block. An aliquot of the fecal suspension was kept at RT and used as a control sample. Then, an aliquot of control and heat-treated samples were further subjected to PtCl~4~ pretreatment and processed as detailed above. In parallel, HAV suspensions in PBS at approx. 6 log~10~ TCID~50~/ml were incubated at 60, 72, and 95°C for 15 min. An aliquot of HAV suspension was kept at RT as a control. After thermal treatment, heat-treated, and control samples were further subject to infectivity assay on FRhk-4 cells, RT-qPCR, PMAxx-RT-qPCR, and PtCl~4~-RT-qPCR as described above. Experiments were performed in triplicate.

Performance of PtCl~4~ Pretreatments to Discriminate Potentially Infectious and Inactivated HEV and HAV by HPP
--------------------------------------------------------------------------------------------------------------

High-pressure processing treatments were performed in a pilot-scale unit (High-Pressure Food Processor, EPSI NV, Belgium) with a vessel operating pressure of 2.35 liters and a maximum treatment pressure of 600 MPa. The pressure transmitting fluid was a mixture of water and ethylene glycol (70:30, v:v). HAV and HEV suspensions were diluted in PBS at approx. 5--6 log~10~ IU/ml and placed in completely full PCR tubes. Tubes were placed in polyethylene bags and heat-sealed (MULTIVAC Thermosealer) before being placed in the HPP unit and pressurized at 500 MPa for 15 min at 29 ± 2°C. After completing the treatment, the samples were immediately stored at −80°C. Before RNA extraction, PMAxx, and PtCl~4~ pretreatments were performed as described above. Two types of controls were included in the experiments: potentially infectious viruses and HPP-treated viruses without PtCl~4~ and PMAxx treatment.

Statistical Analysis
--------------------

Data were statistically analyzed by STATISTICA software (StatSoft Inc., Tulsa, OK, United States) applying one-way analysis of variance (ANOVA) to test the impact of different factors. When significant differences were determined on the means, a multiple comparison procedure (Tukey's honest significant difference, HSD) was applied to determine which factor was significantly different from the others. In all cases, values of *p* \< 0.05 were deemed significant.

Results and Discussion
======================

Evaluation of Intercalating Dye Treatment on Purified HEV RNA
-------------------------------------------------------------

Last year, the European Food Safety authority published recommendations for research needs regarding HEV and food, recommending that the average level of contamination in foods be quantitatively estimated and the correlation between HEV RNA detection and the infectivity of the virus be determined ([@B36]). Currently, RT-qPCR is the gold standard method for HEV detection in food ([@B48]); however, RT-qPCR does not always correlate with the number of infectious virus particles. Therefore, the use of strategies to remove the RT-qPCR signals from inactivated viruses will foster the reliability of risk assessment associated with food samples ([@B4]).

The first experiments evaluated the efficacy of PMAxx on HEV suspension but PMAxx was not working (data not shown). Therefore, the authors decided to evaluate if PMAxx was binding to the HEV RNA and several RT-qPCR assays with different region targets and amplicon sizes were tested (**Table [1](#T1){ref-type="table"}**), as well as compare to PtCl~4~.

Initially, HEV RNA was treated with PMAxx concentrations ranging from 50 to 250 μM and PtCl~4~ concentrations ranging from 50 to 1000 μM. Overall, PMAxx was found to be less efficient than PtCl~4~ pretreatment irrespective of the RT-qPCR assays tested (**Table [2](#T2){ref-type="table"}**). PMAxx reduced by 1.64 to 2.86 Cqs the RT-qPCR signal of assays A and B, while higher reductions were achieved by assay C (10.5 Cqs), suggesting that the longer the amplicon size, the more efficient the PCR signal elimination ([@B51]). It is worth mentioning that the targeted regions of the three RT-qPCR assays were different (**Table [1](#T1){ref-type="table"}**), so the distinct PMAxx performances may also be due to RNA secondary structures ([@B5]; [@B13]). Compared to PMAxx, PtCl~4~ enabled higher reductions of the RT-qPCR signal for HEV RNA regardless of the assay tested. In particular, assay C completely removed the RT-qPCR signal at 50 μM (**Table [2](#T2){ref-type="table"}**). Similar achievements were recently reported for NoV GII and murine norovirus (MNV) purified RNA, where PtCl~4~ (1000 μM) reduced by more than 3 log~10~ both NoV and MNV titers compared to control, while PMAxx (50 μM) reduced the RT-qPCR signal by only 1.6 and 2.5 log~10~, respectively ([@B13]).

###### 

Binding of intercalating dyes to purified HEV RNA using different RT-qPCR assays.

  Intercalating dye   Concentration (μM)   Assay A ([@B41])   Assay B ([@B20])   Assay C ([@B24])                            
  ------------------- -------------------- ------------------ ------------------ ------------------- ------- --------------- ------
  PMAxx               0                    23.03 ± 0.62A      --                 24.78 ± 1.15A       --      26.54 ± 0.27A   --
                      50                   25.46 ± 0.26B      2.43               26.89 ± 0.30A       2.11    35.83 ± 1.24B   9.29
                      100                  25.70 ± 0.44B      2.67               27.36 ± 0.65A       2.58    37.04 ± 1.19B   10.5
                      250                  24.67 ± 0.35B      1.64               27.64 ± 2.24A       2.86    34.98 ± 0.57B   8.44
  PtCl~4~             0                    22.55 ± 0.10A      --                 25.08 ± 0.76A       --      24.49 ± 0.89    --
                      50                   36.92^∗^B          14.37              35.61 ± 6.21^∗∗^A   10.53   nd              --
                      100                  38.19^∗^C          16.64              39.46^∗^A           14.38   nd              --
                      500                  nd                 --                 35.03 ± 0.40^∗∗^A   9.95    nd              --
                      1000                 nd                 --                 nd                  --      nd              --

Quantification cycle (Cq) represents the PCR cycle at which the probe-specific fluorescent signal can be detected against the background. nd, not detected;

∗

one positive sample out of four;

∗∗

two positive samples out of four. Different letters denote significant differences among treatments according to Tukey HSD test (p \< 0.05).

Performance of PtCl~4~ treatment combined with assay C was slightly better than PtCl~4~ treatment combined with assay A. However, assay A was further used to evaluate the performance of the PtCl~4~ treatment because its better detection limit.

Performance of the PtCl~4~ Pre-treatment to Discriminate Potentially Infectious and Thermally Inactivated HEV
-------------------------------------------------------------------------------------------------------------

Although some laboratories have successfully cultivated HEV in cell culture ([@B50]), there are limitations that need to be overcome before these methods can routinely be used. In the meantime, evaluation of the thermal inactivation of HEV has been performed using animal models, HEV surrogates and capsid integrity assays ([@B4]; [@B50]).

From this perspective, one of the main challenges for both researchers and food industries is to be able to infer HEV infectivity by using a rapid and quantitative method, such as viability RT-qPCR. Photoactivatable intercalating dyes have begun to show promise in being able to selectively detect infectious HAV ([@B38]; [@B6]; [@B28]; [@B14]; [@B33]) and human NoV ([@B30]; [@B35], [@B32]; [@B18]). Recently, [@B13] proposed PtCl~4~ as a successful viability marker for human NoV.

As a first step in exploring the potential of PtCl~4~ to discriminate between potentially infectious and thermally inactivated HEV by RT-qPCR, HEV suspensions were inactivated by incubating them at 99°C for 5 min and treated with 500 μM PtCl~4~ for 30 min at 5°C. Results showed that PtCl~4~ significantly reduced (*p* \< 0.05) the signal of inactivated HEV by 2.8 and \>2.8 log~10~ with respect to the initial titer concentration of 4 and 5 log~10~ IU/ml, respectively (**Table [3](#T3){ref-type="table"}**). It is worth mentioning that PtCl~4~ completely removed the RT-qPCR signal when tested with the lower HEV concentration. One limitation of the current study was the use of a fecal sample containing unknown concentration and ratio of infectious to non-infectious virus particles, however, we observed that fecal sample mainly contained infectious viruses since the signal of PtCl~4~-treated fecal suspension was reduced by less than 0.5 log~10~ (**Table [3](#T3){ref-type="table"}**).

###### 

Quantification of thermally inactivated HEV suspensions by RT-qPCR (Assay A; [@B41]).

                PtCl~4~ 500 μM   Titer of HEV RNA                           
  ------------- ---------------- ------------------ -------- -------------- ------
  Infectious    --               4.92 ± 0.10AB      --       5.68 ± 0.15A   --
                \+               4.67 ± 0.23A       0.26     5.27 ± 0.01B   0.41
  Inactivated   --               5.12 ± 0.12B       --       5.73 ± 0.13A   --
                \+               \<LOQ^b^C          \>2.80   2.93 ± 0.19C   2.80

a

, Reduction in titers between PtCl

4

treated and non-treated viruses;

b

, LOQ = 2.12 log

10

IU/ml. Different letters denote significant differences among treatments for each virus according to Tukey HSD test (p \< 0.05).

Performance of the Pre-treatment to Monitor Influence of Heat Processing on HEV and HAV
---------------------------------------------------------------------------------------

Moreover, the effect of exposure to different temperatures on the RNA detection of HEV after PtCl~4~ treatment was compared with the effect on HAV infectivity and RNA detection after intercalating dye treatment. PMAxx combined with Triton has been reported to be the most efficient intercalating dye for assessing HAV infectivity using RT-qPCR ([@B32]), so the performance of PtCl~4~ treatment was compared with the PMAxx-Triton treatment. Like our previous results ([@B32]), the thermal treatment at 60, 72, and 95°C produced a higher degree of inactivation as estimated by the infectivity assay than PMAxx-Triton pretreatment combined with RT-qPCR.

After pretreatment with PMAxx-Triton, HAV titers showed 0.6, 3.3, and \>4.2-log~10~ reductions and 0.2, 0.7, and 2.2-log~10~ reductions after pretreatment with PlCt4, when heated at 60, 72, and 95°C, respectively (**Figure [1](#F1){ref-type="fig"}**). Thus, PMAxx performed better than PtCl~4~ in discriminating between potentially infectious and thermally treated HAV suspensions. In fact, remarkable HAV reduction (approx. 2.2-log~10~ genome copies/ml) assessed by PtCl~4~-RT-qPCR was detected only after 15 min treatment at 95°C (**Figure [1B](#F1){ref-type="fig"}**). However, despite this notable outcome with PtCl~4~ pretreatment, PMAxx-RT-qPCR performed even better, sharply differentiating thermally treated HAV viral particles at 72 and 95°C (reduction of 3.4 and \>6-log~10~ genome copies/ml, respectively) (**Figure [1B](#F1){ref-type="fig"}**). Similarly, a previous study conducted in our lab showed that HAV infectivity correlated with PMAxx-RT-qPCR for heat inactivations at 72 and 95°C, but not at 60°C ([@B32]). Overall, PMAxx pretreatment data showed better pattern matching with cell culture than PtCl~4~-RT-qPCR, suggesting the former as the best approach to infer HAV infectivity by molecular methods.

![Performance of tissue culture infectious dose (TCID~50~), RT-qPCR, PMAxx-RT-qPCR, and PtCl~4~-RT-qPCR to discriminate between infectious and heat-treated HEV **(A)** and HAV **(B)** at 60, 72, and 95°C for 15 min. Asterisks (^∗^) denote significant differences among viability treated samples (PMAxx or PtCl~4~) and the control (RT-qPCR) for each temperature (*p* \< 0.05). Dashed and continuous gray lines represent the limit of quantification of HAV by TCID~50~ and RT-qPCR, respectively.](fmicb-09-01973-g001){#F1}

With regards to HEV, approximately 2-log~10~ reduction was detected by PtCl~4~-RT-qPCR at both 72 and 95°C, while less than 1-log~10~ decrease was shown at 60°C, suggesting the need to further optimize the pretreatment (**Figure [1A](#F1){ref-type="fig"}**). In this sense, different conditions of the pretreatment in terms of time and temperature, and the use of enhancers ([@B35]; [@B13]) may be tested in future assays, especially in challenging tests with food samples, where the matrix could interfere with the ability of the compound to interact with nucleic acids.

The heat resistance of HEV and HAV has previously been compared in a cumbersome cell culture system that was permissive for both viruses ([@B12]). In particular, different HEV strains were compared showing inactivation temperatures ranging between 56--60°C, while HAV particles tolerated temperatures 5--10°C higher. The results of this study are in accordance with these reported inactivation rates since HAV treated at 60°C for 15 min was still able to replicate in FRhK cells, while higher temperatures (i.e., 72°C) completely inactivated it. Moreover, while HEV inactivated at 60°C showed statistically significant reductions when pretreated with PtCl~4~, even sharper discriminations were recorded at higher temperatures (**Figure [1A](#F1){ref-type="fig"}**).

Hepatitis E virus can remain infectious at temperatures used in some cooking regimes, although inactivation by heating at 71°C for 20 min has been demonstrated ([@B48]). Some discrepancies have been reported in studies especially when temperatures around 70°C are compared. So far, complete inactivation has been reported by cell culture methods after heat treatments at 60°C for 1 h, 70°C for 2 min, and 80°C for 1 min ([@B12]; [@B19]). HEV was inactivated when heated at 71°C for 20 min, but not at 71°C for 5 min when evaluated by inoculating pigs ([@B1]).

Some differences have been recently reported by [@B17] who studied HEV inactivation by measuring virus replication in PLC/PRF/5 cell culture. The results showed that exposure to 65°C for 5 min or 75°C for 1 min inactivated HEV-3, while HEV-4 was inactivated at 80°C for 1 min. Thereby, a different sensitivity of HEV genotypes to thermal treatments was also observed.

To date, to our best knowledge only [@B40] have investigated the effect of temperatures on HEV survival using a capsid integrity assay consisting of a RNase pretreatment followed by RT-qPCR. The results showed reductions of 0.5 and 3.7 log~10~ after 1 min at 70 and 95°C, respectively, in accordance with published cell culture-based data ([@B15]; [@B12]; [@B46]). The authors concluded that the RNase-based method may provide data on the stability of RNA viruses. However, other authors agree on the lack of correlation among data originating from viability PCR and cell culture methods, resulting in viral infectivity usually being overestimated when assessed by molecular approaches ([@B40]; [@B19]).

Performance of the Pre-treatment to Monitor High Pressure Processing Treated HEV and HAV
----------------------------------------------------------------------------------------

High-pressure processing is a non-thermal, cold processing technique used by the food industry for inactivating microorganisms and extending shelf life, while having little effect on sensorial and nutritional quality of foods. HPP is industrially applied to fruit juices, jams, meat products, and ready-to-eat vegetables with pressures typically ranging between 400 and 600 MPa for 3 to 30 min ([@B16]; [@B37]). To date, no information is available on reductions of HEV by HPP. In this study, HEV and HAV suspensions were subjected to 500 MPa for 15 min, and cell culture assays for HAV showed that the evaluated HPP treatment completely inactivated HAV. However, a fraction of HPP-inactivated HEV were still detected by the PtCl~4~-RT-qPCR assay (**Figure [2](#F2){ref-type="fig"}**), indicating that RNA of HPP-inactivated HEV was not completely accessible to PtCl~4~. Regarding HAV, none of the viability pretreatments showed significant differences with respect to the control (*p* \> 0.05), while the infectivity assay showed complete inactivation after 15 min of treatment at 500 MPa (**Figure [2](#F2){ref-type="fig"}**).

![Performance of RT-qPCR, PMAxx-RT-qPCR, and PtCl~4~-RT-qPCR to discriminate between infectious and non-infectious HEV and HAV after HPP inactivation at 500 MPa for 15 min. Different letters denote significant differences among each assay for each virus (*p* \< 0.05). ^∗^, PMAxx-RT-qPCR was not performed for HEV. Dashed yellow line depicts the limit of quantification of HEV by RT-qPCR and the dashed black line depicts the limit of quantification of HAV by TCID~50~.](fmicb-09-01973-g002){#F2}

Conclusion
==========

The lack of a convenient cell-culture method for HEV has limited inactivation studies. RT-qPCR procedures are the gold standard for virus detection. Thus, we report, for the first time, the development of a rapid viability molecular assay to infer HEV infectivity. Our results suggest that PtCl~4~ pretreatment successfully discriminates between native, thermal-, and HPP-treated HEV, to different extents depending on the experimental conditions. In contrast, we found PMAxx to better discriminate between thermal-, but not HPP-, treated HAV, showing a closer inactivation trend to cell culture data than PtCl~4~. Although these viability procedures may still overestimate infectivity,these results suggest a wide range of options to assess the efficiency of thermal and HPP treatments in inactivating HEV in food products, ultimately constituting a powerful tool for risk assessment studies.
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